[Seite 79↓]

Literaturverzeichnis

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000 Mar 2, 342(9): S.605-12.

2. Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial. Lancet. 1982 Jul 10, 2(8289): S.57-60.

3. Cosimi AB, Burton RC, Colvin RB, Goldstein G, Delmonico FL, LaQuaglia MP, Tolkoff-Rubin N, Rubin RH, Herrin JT, Russell PS: Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation. 1981 Dec, 32(6): S.535-9.

4. Denton MD, Magee CC, Sayegh MH: Immunosuppressive strategies in transplantation. Lancet. 1999 Mar 27, 353(9158): S.1083-91.

5. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002 Feb 21, 346(8): S.580-90.

6. Cecka JM: The UNOS Scientific Renal Transplant Registry. Clin Transpl. 1999, 1-21.

7. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995 Aug 10, 333(6): S.333-6.

8. Tullius SG, Tilney NL: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation. 1995 Feb 15, 59(3): S.313-8.

9. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997 Apr 15, 63(7): S.968-74.

10. Halloran PF, Melk A, Barth C: Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol. 1999 Jan, 10(1): S.167-81.


[Seite 80↓]

11. Smits JM, van Houwelingen HC, De Meester J, le Cessie S, Persijn GG, Claas FH, Frei U: Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation. 2000 Jul 27, 70(2): S.317-23.

12. Land W, Messmer K: The Impact of Ischemia / Reperfusion Injury on Specific and Non-Specific, Early and Late Chronic Events After Organ Transplantation. Transplantation Reviews. 1996 April, Vol 10, No2: S.108-27.

13. Menger MD, Steiner D, Messmer K: Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow". Am J Physiol. 1992 Dec, 263(6 Pt 2): S.H1892-900.

14. Williams GM: Quantitation of free radical-mediated reperfusion injury in renal transplantation. Methods Enzymol. 1990, 186: S.748-51.

15. Schneeberger H, Schleibner S, Illner WD, Messmer K, Land W: The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation. Clin Transpl. 1993, S.219-32.

16. Davenport A, Hopton M, Bolton C: Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograft transplantation and the effect on early graft function. Clin Transplant. 1995 Jun, 9(3 Pt 1): S.171-5.

17. Introna M, Breviario F, d'Aniello E, Luchetti MM, Vidal V, Dejana E, Mantovani A: Cytokine regulation of endothelial cell function. Behring Inst Mitt. 1993 Aug, (92): S.23-9.

18. Ebnet K, Kaldjian EP, Anderson AO, Shaw S: Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol. 1996, 14: S.155-77.

19. Connolly JK, Guy SP, Parrott NR: Cytokine gene expression and eicosanoid production in renal reperfusion injury. Transplant Proc. 1995 Oct, 27(5): S.2816-8.

20. Solez K, Racusen LC, Abdulkareem F, Kemeny E, von Willebrand E, Truong LD: Adhesion molecules and rejection of renal allografts. Kidney Int. 1997 May, 51(5): S.1476-80.

21. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR: Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 1997 May, 51(5): S.1463-8.


[Seite 81↓]

22. Fuggle SV, Koo DD: Cell adhesion molecules in clinical renal transplantation. Transplantation. 1998 Mar 27, 65(6): S.763-9.

23. Nemoto T, Burne MJ, Daniels F, O'Donnell MP, Crosson J, Berens K, Issekutz A, Kasiske BL, Keane WF, Rabb H: Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int. 2001 Dec, 60(6): S.2205-14.

24. Cosimi AB, Conti D, Delmonico FL, Preffer FI, Wee SL, Rothlein R, Faanes R, Colvin RB: In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol. 1990 Jun 15, 144(12): S.4604-12.

25. Haller H, Maasch C, Dragun D, Wellner M, Haller H, Dragun D, Miethke A, Park JK, Weis A, Lippoldt A, Gross V, Luft FC: Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int. 1996 Aug, 50(2): S.473-80.

26. Dragun D, Tullius SG, Park JK, Maasch C, Lukitsch I, Lippoldt A, Gross V, Luft FC, Haller H: ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int. 1998 Aug, 54(2): S.590-602.

27. Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV: Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol. 1998 Aug, 153(2): S.557-66.

28. Gaber LW, Gaber AO, Tolley EA, Hathaway DK: Prediction by postrevascularization biopsies of cadaveric kidney allografts of rejection, graft loss, and preservation nephropathy. Transplantation. 1992 Jun, 53(6): S.1219-25.

29. Hourmant M, Bedrossian J, Durand D, Lebranchu Y, Renoult E, Caudrelier P, Buffet R, Soulillou JP: A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation. 1996 Dec 15, 62(11): S.1565-70.


[Seite 82↓]

30. Salmela K, Wramner L, Ekberg H, Hauser I, Bentdal O, Lins LE, Isoniemi H, Backman L, Persson N, Neumayer HH, Jorgensen PF, Spieker C, Hendry B, Nicholls A, Kirste G, Hasche G: A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation. 1999 Mar 15, 67(5): S.729-36.

31. Brown EJ: Adhesive interactions in the immune system. Trends in Cell Biology. 1997 July, Vol. 7: S.289-95.

32. Muller WA: Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 2003 Jun, 24(6): S.327-34.

33. Bevilacqua MP, Nelson RM: Selectins. J Clin Invest. 1993 Feb, 91(2): S.379-87.

34. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA: Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood. 1996 Jul 1, 88(1): S.146-57.

35. Dunon D, Piali L, Imhof BA: To stick or not to stick: the new leukocyte homing paradigm. Curr Opin Cell Biol. 1996 Oct, 8(5): S.714-23.

36. Bullard DC, Kunkel EJ, Kubo H, Hicks MJ, Lorenzo I, Doyle NA, Doerschuk CM, Ley K, Beaudet AL: Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med. 1996 May 1, 183(5): S.2329-36.

37. Stewart M, Thiel M, Hogg N: Leukocyte integrins. Curr Opin Cell Biol. 1995 Oct, 7(5): S.690-6.

38. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994 Jan 28, 76(2): S.301-14.

39. Smyth SS, Joneckis CC, Parise LV: Regulation of vascular integrins. Blood. 1993 Jun 1, 81(11): S.2827-43.

40. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA: The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol. 1995 Mar, 128(6): S.1243-53.

41. Hemler ME, Lobb RR: The leukocyte beta 1 integrins. Curr Opin Hematol. 1995 Jan, 2(1): S.61-7.

42. Lub M, van Kooyk Y, Figdor CG: Ins and outs of LFA-1. Immunol Today. 1995 Oct, 16(10): S.479-83.


[Seite 83↓]

43. Diamond MS, Springer TA: A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol. 1993 Jan, 120(2): S.545-56.

44. Springer TA: Adhesion receptors of the immune system. Nature. 1990 Aug 2, 346(6283): S.425-34.

45. Marlin SD, Springer TA: Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 1987 Dec 4, 51(5): S.813-9.

46. van de Stolpe A, van der Saag PT: Intercellular adhesion molecule-1. J Mol Med. 1996 Jan, 74(1): S.13-33.

47. Wuthrich RP: Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney. J Am Soc Nephrol. 1992 Dec, 3(6): S.1201-11.

48. Xu H, Bickford JK, Luther E, Carpenito C, Takei F, Springer TA: Characterization of murine intercellular adhesion molecule-2. J Immunol. 1996 Jun 15, 156(12): S.4909-14.

49. Issekutz AC, Rowter D, Springer TA: Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration. J Leukoc Biol. 1999 Jan, 65(1): S.117-26.

50. de Fougerolles AR, Qin X, Springer TA: Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med. 1994 Feb 1, 179(2): S.619-29.

51. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R: Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989 Dec 22, 59(6): S.1203-11.

52. Siegelman MH, Stanescu D, Estess P: The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion. J Clin Invest. 2000 Mar, 105(5): S.683-91.

53. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC: alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 1995 Feb 10, 80(3): S.413-22.


[Seite 84↓]

54. Shang XZ, Issekutz AC: Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers. Eur J Immunol. 1998 Jun, 28(6): S.1970-9.

55. Chuluyan HE, Osborn L, Lobb R, Issekutz AC: Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration. J Immunol. 1995 Sep 15, 155(6): S.3135-4.

56. van Wetering S, van den Berk N, van Buul JD, Mul FP, Lommerse I, Mous R, ten Klooster JP, Zwaginga JJ, Hordijk PL: VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol. 2003 Aug, 285(2): S.343-52.

57. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993 Aug 1, 178(2): S.449-60.

58. Thompson RD, Wakelin MW, Larbi KY, Dewar A, Asimakopoulos G, Horton MA, Nakada MT, Nourshargh S: Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivo. J Immunol. 2000 Jul 1, 165(1): S.426-34.

59. Druid H, Enestrom S, Rammer L: Effect of anticoagulation upon nephron obstruction in experimental acute ischaemic renal failure. A morphological study. Int J Exp Pathol. 1998 Feb, 79(1): S.55-66.

60. Edgington TS, Mackman N, Brand K, Ruf W: The structural biology of expression and function of tissue factor. Thromb Haemost. 1991 Jul 12, 66(1): S.67-79.

61. Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989 May, 134(5): S.1087-97.

62. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Muller M, Bohrer H, Greten J, et al: Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem. 1995 Nov 3, 270(44): S.26419-32.

63. Nemerson Y: Tissue factor and hemostasis. Blood. 1988 Jan, 71(1): S.1-8.

64. Randolph GJ, Luther T, Albrecht S, Magdolen V, Muller WA: Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood. 1998 Dec 1, 92(11): S.4167-77.


[Seite 85↓]

65. Fan ST, Mackman N, Cui MZ, Edgington TS: Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. J Immunol. 1995 Apr 1, 154(7): S.3266-74.

66. Ushigome H, Sano H, Okamoto M, Kadotani Y, Nakamura K, Akioka K, Yoshimura R, Ohmori Y, Yoshimura N: The role of tissue factor in renal ischemic reperfusion injury of the rat. J Surg Res. 2002 Feb, 102(2): S.102-9.

67. Matsuyama M, Yoshimura R, Akioka K, Okamoto M, Ushigome H, Kadotani Y, Nakatani T, Yoshimura N: Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury. Transplantation. 2003 Sep 15, 76(5): S.786-91.

68. Bukovsky A, Labarrere CA, Haag B, Carter C, Faulk WP: Tissue factor in normal and transplanted human kidneys. Transplantation. 1992 Oct, 54(4): S.644-50.

69. Krieger NR, Yin DP, Fathman CG: CD4+ but not CD8+ cells are essential for allorejection. J Exp Med. 1996 Nov 1, 184(5): S.2013-8.

70. Sayegh M: Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int. 1999 Nov, 56(5): S.1967-79.

71. Fox A, Harrison LC: Innate immunity and graft rejection. Immunol Rev. 2000 Feb, 173: S.141-7.

72. Austyn JM, Larsen CP: Migration patterns of dendritic leukocytes. Implications for transplantation. Transplantation. 1990 Jan, 49(1): S.1-7.

73. Sayegh MH, Turka LA: The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med. 1998 Jun 18, 338(25): S.1813-21.

74. Batchelor JR: Transplant immunology. Transplant Proc. 1994 Aug, 26(4): S.1875-6.

75. Steele DJ, Laufer TM, Smiley ST, Ando Y, Grusby MJ, Glimcher LH, Auchincloss H Jr: Two levels of help for B cell alloantibody production. J Exp Med. 1996 Feb 1, 183(2): S.699-703.

76. Vella JP, Spadafora-Ferreira M, Murphy B, Alexander SI, Harmon W, Carpenter CB, Sayegh MH: Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation. 1997 Sep 27, 64(6): S.795-800.


[Seite 86↓]

77. Samaniego M, Baldwin WM, Sanfilippo F: Delayed graft function: immediate and late impact. Curr Opin Nephrol Hypertens. 1997 Nov, 6(6): S.533-7.

78. Lechevallier E, Dussol B, Luccioni A, Thirion X, Vacher-Copomat H, Jaber K, Brunet P, Leonetti F, Lavelle O, Coulange C, Berland Y: Posttransplantation acute tubular necrosis: risk factors and implications for graft survival. Am J Kidney Dis. 1998 Dec, 32(6): S.984-91.

79. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999 Feb, 55(2): S.713-23.

80 . Paul LC: Animal models of chronic heart and kidney allograft rejection. Transplant Proc. 1993 Apr, 25(2): S.2080-1.

81 . Herrero-Fresneda I, Torras J, Cruzado JM, Condom E, Vidal A, Riera M, Lloberas N, Alsina J, Grinyo JM: Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy. Am J Pathol. 2003 Jan, 162(1): S.127-37.

82 . Pratschke J, Wilhelm MJ, Laskowski I, Kusaka M, Beato F, Tullius SG, Neuhaus P, Hancock WW, Tilney NL: Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol. 2001 Nov, 12(11):S.2474-81.

83 . Kauffman HM, Bennett LE, McBride MA, Ellison MD: The expanded donor. Transplant Rev. 1997, 11:S.165-190.

84 . Epstein M: Aging and the kidney. J Am Soc Nephrol. 1996 Aug, 7(8):S.1106-22.

85 . Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Gores PF, Gruessner RW, Najarian JS: Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation. 1993 May, 55(5): S.993-5.

86 . van Saase JL, van der Woude FJ, Thorogood J, Hollander AA, van Es LA, Weening JJ, van Bockel JH, Bruijn JA: The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation. 1995 May, 15 59(9) : S.1280-5.


[Seite 87↓]

87 . Held PJ, Kahan BD, Hunsicker LG, Liska D, Wolfe RA, Port FK, Gaylin DS, Garcia JR, Agodoa LY, Krakauer H: The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med. 1994 Sep 22, 331(12) : S.765-70.

88 . Connolly JK, Dyer PA, Martin S, Parrott NR, Pearson RC, Johnson RW: Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. Transplantation. 1996 Mar, 15 61(5) : S.709-14.

89 . Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW: Significance of the donor age effect on kidney transplants. Clin Transplant. 1997 Oct, 11(5 Pt 1) : S. 366-72.

90 . Homan WP, Fabre JW, Williams KA, Millard PR, Morris PJ: Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation. 1980 May, 29(5) : S. 361-6.

91 . Klausner JM, Paterson IS, Goldman G, Kobzik L, Rodzen C, Lawrence R, Valeri CR, Shepro D, Hechtman HB: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol. 1989 May, 256(5 Pt 2) : S.794-802.

92 . Linas SL, Whittenburg D, Parsons PE, Repine JE: Ischemia increases neutrophil retention and worsens acute renal failure: role of oxygen metabolites and ICAM 1. Kidney Int. 1995 Nov, 48(5) : S.1584-91.

93 . Rabb H, Mendiola CC, Dietz J, Saba SR, Issekutz TB, Abanilla F, Bonventre JV, Ramirez G: Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol. 1994 Dec. 267(6 Pt 2) : S.1052-8.

94 . Ghielli M, Verstrepen W, Nouwen E, De Broe ME: Regeneration processes in the kidney after acute injury: role of infiltrating cells. Exp Nephrol. 1998 Nov-Dec, 6(6) : S.502-7.

95 . Halloran PF, Homik J, Goes N, Lui SL, Urmson J, Ramassar V, Cockfield SM: The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc. 1997 Feb-Mar, 29(1-2) : S.79-81.

96 . Lu CY, Penfield JG, Kielar ML, Vazquez MA, Jeyarajah DR: Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process. Kidney Int. 1999 Jun, 55(6) : S.2157-68.


[Seite 88↓]

97 . Olsen S, Burdick JF, Keown PA, Wallace AC, Racusen LC, Solez K: Primary acute renal failure ("acute tubular necrosis") in the transplanted kidney: morphology and pathogenesis. Medicine (Baltimore). 1989 May, 68(3) : S.173-87.

98 . Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int. 1993 May, 43(5) : S.1160-78.

99 . Jones DA, Smith CW, Picker LJ, McIntire LV: Neutrophil adhesion to 24-hour IL-1-stimulated endothelial cells under flow conditions. J Immunol. 1996 Jul 15, 157(2) : S.858-63.

100 . Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A. 1994 Jan 18, 91(2) : S.812-6.

101 . Fuggle SV, Sanderson JB, Gray DW, Richardson A, Morris PJ: Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys--correlation with intragraft events. Transplantation. 1993 Jan, 55(1) : S.117-23.

102 . Gibbs P, Berkley LM, Bolton EM, Briggs JD, Bradley JA: Adhesion molecule expression (ICAM-1, VCAM-1, E-selectin and PECAM) in human kidney allografts. Transpl Immunol. 1993, 1(2) : S.109-13.

103 . Bevilacqua MP, Nelson RM, Mannori G, Cecconi O: Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med. 1994, 45 : S.361-78.

104 . Hauser IA, Riess R, Hausknecht B, Thuringer H, Sterzel RB: Expression of cell adhesion molecules in primary renal disease and renal allograft rejection. Nephrol Dial Transplant. 1997 Jun, 12(6) : S.1122-31.

105 . Renkonen R, Turunen JP, Rapola J, Hayry P: Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection. Am J Pathol. 1990 Se, 137(3) : S.643-51.

106 . Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broe ME: Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant. 2000 Oct, 15(10) : S.1562-74.


[Seite 89↓]

107 . Hoffmann SC, Kampen RL, Amur S, Sharaf MA, Kleiner DE, Hunter K, John Swanson S, Hale DA, Mannon RB, Blair PJ, Kirk AD: Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation. 2002 Oct, 15 74(7) : S.916-23.

108 . Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, Rabb H: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest. 2001 Nov, 108(9) : S.1283-90.

109 . De Greef KE, Ysebaert DK, Dauwe S, Persy V, Vercauteren SR, Mey D, De Broe ME: Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 2001 Oct, 60(4) : S.1415-27.

110 . Johnston B, Walter UM, Issekutz AC, Issekutz TB, Anderson DC, Kubes P: Differential roles of selectins and the alpha4-integrin in acute, subacute, and chronic leukocyte recruitment in vivo. J Immunol. 1997 Nov 1, 159(9) : S. 4514-23.

111 . Erwig LP, Rees AJ: Macrophage activation and programming and its role for macrophage function in glomerular inflammation. Kidney Blood Press Res. 1999, 22(1-2) : S.21-5.

112 . Grimm PC, McKenna R, Nickerson P, Russell ME, Gough J, Gospodarek E, Liu B, Jeffery J, Rush DN: Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol. 1999 Jul, 10(7) : S.1582-9.

113 . Roodnat JI, Mulder PG, Van Riemsdijk IC, IJzermans JN, van Gelder T, Weimar W: Ischemia times and donor serum creatinine in relation to renal graft failure. Transplantation. 2003 Mar 27, 75(6) : S.799-804.

114 . Asderakis A, Dyer P, Augustine T, Worthington J, Campbell B, Johnson RW: Effect of cold ischemic time and HLA matching in kidneys coming from "young" and "old" donors: do not leave for tomorrow what you can do tonight. Transplantation. 2001 Aug 27, 72(4) : S.674-8.

115 . Tandon V, Botha JF, Banks J, Pontin AR, Pascoe MD, Kahn D: A tale of two kidneys--how long can a kidney transplant wait? Clin Transplant. 2000 Jun, 14(3) : S.189-92.

116 . Kouwenhoven EA, de Bruin RW, Heemann UW, Marquet RL, Ijzermans JN Kouwenhoven EA, de Bruin RW, Heemann UW, Marquet RL, Ijzermans JN: Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine. Transplantation. 1999 Oct 15, 68(7) : S.1004-10.


[Seite 90↓]

117 . Yilmaz S, Paavonen T, Hayry P: Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation. 1992 Apr, 53(4) : S.823-7.

118 . Tullius SG, Reutzel-Selke A, Egermann F, Nieminen-Kelha M, Jonas S, Bechstein WO, Volk HD, Neuhaus P: Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J Am Soc Nephrol. 2000 Jul, 11(7) : S.1317-24.

119 . Ploeg RJ, van Bockel JH, Langendijk PT, Groenewegen M, van der Woude FJ, Persijn GG, Thorogood J, Hermans J: Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study Group. Lancet. 1992 Jul 18, 340(8812) : S.129-37.

120 . Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation. 1997 Oct 15, 64(7) : S. 945-7.

121 . Penfield JG, Dawidson IA, Ar'Rajab A, Kielar MA, Jeyarajah DR, Lu CY: Syngeneic renal transplantation increases the number of renal dendritic cells in the rat. Transpl Immunol. 1999 Dec, 7(4) : S.197-200.

122 . Basile DP: Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens. 2004 Jan, 13(1) : S1-7.

123 . Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002 Mar, 13(3) : S.806-16.

124 . Nagayasu T, Saadi S, Holzknecht RA, Plummer TB, Platt JL: Expression of tissue factor mRNA in cardiac xenografts: clues to the pathogenesis of acute vascular rejection. Transplantation. 2000 Feb 27, 69(4) : S.475-82.

125 . Amorino GP, Hoover RL: Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol. 1998 Jan, 152(1) : S.199-207.

126 . Azuma H, Nadeau KC, Ishibashi M, Tilney NL Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation. 1995 Dec 27, 60(12) : S. 1577-82.


[Seite 91↓]

127 . Pilmore HL, Painter DM, Bishop GA, McCaughan GW, Eris JM: Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation. 2000 Jun 27, 69(12) : S.2658-62.

128 . Tullius SG, Heemann U, Hancock WW, Azuma H, Tilney NL: Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg. 1994 Oct, 220(4) : S.425-35.

129 . Nagano H, Nadeau KC, Takada M, Kusaka M, Tilney NL: Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation. 1997 Apr 27, 63(8) : S.1101-8.

130 . Libby P, Pober JS: Chronic rejection. Immunity. 2001 Apr, 14(4) : S.387-97.

131 . Humes HD, Beals TF, Cieslinski DA, Sanchez IO, Page TP: Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells. Lab Invest. 1991 Apr, 64(4) : S.538-45.

132 . Slavin J: Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int. 1995 May, 19(5) : S.431-44.

133 . Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994 Nov 10, 331(19) : S.1286-92.

134 . Strutz F, Neilson EG: New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol. 2003 May, 24(4) : S.459-76.

135 . Cosio FG, Pelletier RP, Sedmak DD, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Pathologic classification of chronic allograft nephropathy: pathogenic and prognostic implications. Transplantation. 1999 Mar 15, 67(5) : S.690-6.

136 . Schwarzacher SP, Uren NG, Ward MR, Schwarzkopf A, Giannetti N, Hunt S, Fitzgerald PJ, Oesterle SN, Yeung AC: Determinants of coronary remodeling in transplant coronary disease: a simultaneous intravascular ultrasound and Doppler flow study. Circulation. 2000 Mar 28, 101(12) : S.1384-9.

137 . Pethig K, Heublein B, Wahlers T, Haverich A: Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate vascular remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis. Working Group on Cardiac Allograft Vasculopathy. Am Heart J. 1998 Apr, 135(4) : S.628-33.


[Seite 92↓]

138 . Solez K, Vincenti F, Filo RS: Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation. 1998 Dec 27, 66(12) : S.1736-40.

139 . Koskinen P, Lemstrom K, Hayry P: Chronic rejection. Curr Opin Nephrol Hypertens. 1996 May, 5(3) : S.269-72.

140 . Solez K: Graft atherosclerosis and chronic rejection in the kidney. Transplant Proc. 1997 Sep, 29(6) : S.2541.

141 . Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14, 340(2) : S.115-26.

142 . Gerszten RE, Lim YC, Ding HT, Snapp K, Kansas G, Dichek DA, Cabanas C, Sanchez-Madrid F, Gimbrone MA Jr, Rosenzweig A, Luscinskas FW: Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. Circ Res. 1998 May, 4 82(8) : S.871-8.

143 . Dragun D, Lukitsch I, Tullius SG, Qun Y, Park JK, Schneider W, Luft FC, Haller H: Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat. Kidney Int. 1998 Dec, 54(6) : S.2113-22.

144 . Humes HD, Lake EW, Liu S: Renal tubule cell repair following acute renal injury. Miner Electrolyte Metab. 1995, 21(4-5) : S.353-65.

145 . Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest. 1989 Dec, 84(6) : S.1757-61.

146 . Cuevas P, Martinez-Coso V, Fu X, Orte L, Reimers D, Gimenez-Gallego G, Forssmann WG, Saenz De Tejada I: Fibroblast growth factor protects the kidney against ischemia-reperfusion injury. Eur J Med Res. 1999 Oct 15, 4(10) : S.403-10.

147 . Docherty NG, Perez-Barriocanal F, Balboa NE, Lopez-Novoa JM: Transforming growth factor-beta1 (TGF-beta1): a potential recovery signal in the post-ischemic kidney. Ren Fail, 2002 Jul, 24(4) : S.391-406.

148 . Nakatani T, Kim T, Uchida J, Kumata N, Kawashima H, Sugimura K: Hepatocyte growth factor ameliorates renal hemodynamic disorder after ischemia/reperfusion. Int J Mol Med. 2002 Aug, 10(2) : S.217-9.


[Seite 93↓]

149 . Shihab FS, Tanner AM, Shao Y, Weffer MI: Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int. 1996 Dec, 50(6) : S.1904-13.

150 . Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH: Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A, 1996 Oct 29, 93(22) : S.12439-44.

151 . Glysing-Jensen T, Raisanen-Sokolowski A, Sayegh MH, Russell ME: Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts. Transplantation. 1997 Dec 27, 64(12) : S.1641-5.

152 . St Peter SD, Imber CJ, Friend PJ: Liver and kidney preservation by perfusion. Lancet. 2002 Feb 16, 359(9306) : S.604-13.

153 . Polyak MM, Arrington BO, Stubenbord WT, Boykin J, Brown T, Jean-Jacques MA, Estevez J, Kapur S, Kinkhabwala M: The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation. 2000 Jan 27, 69(2) : S.249-58.

154 . Hong JC, Kahan BD: Immunosuppressive agents in organ transplantation: past, present, and future. Semin Nephrol. 2000 Mar, 20(2) : S.108-25.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
17.05.2005